Biology Reference
In-Depth Information
Mazier, D., Landau, I., Miltgen, F., Druilhe, P., Guguen-Guillouzo, C., et al., 1983. In vitro
infestation of human hepatocytes by sporozoites of
Plasmodium vivax
: schizogony and
liberation of merozoites capable of infesting human erythrocytes. Ann. Parasitol. Hum.
Comp. 58, 405-406.
Mendis, K., Sina, B.J., Marchesini, P., Carter, R., 2001. The neglected burden of Plasmodium
vivax malaria. Am. J. Trop. Med. Hyg. 64, 97-106.
Millet, P., Collins, W.E., Herman, L., Cochrane, A.H., 1989.
Plasmodium vivax
: in vitro devel-
opment of exoerythrocytic stages in squirrel monkey hepatocytes and inhibition by an
anti-
P. cynomolgi
monoclonal antibody. Exp. Parasitol. 69, 91-93.
Milne, L.M., Kyi, M.S., Chiodini, P.L., Warhurst, D.C., 1994. Accuracy of routine laboratory
diagnosis of malaria in the United Kingdom. J. Clin. Pathol. 47, 740-742.
Most, H., Kane, C.A., et al., 1946a. Combined quinine-plasmochin treatment of vivax
malaria; effect of relapse rate. Am. J. Med. Sci. 212, 550-560.
Most, H., London, I.M., et al., 1946b. Chloroquine for treatment of acute attacks of vivax
malaria. J. Am. Med. Assoc. 131, 963-967.
Munteis, E., Mellibovsky, L., Marquez, M.A., Minguez, S., Vazquez, E., et al., 1997. Pulmo-
nary involvement in a case of
Plasmodium vivax
malaria. Chest 111, 834-835.
Mwangi, T.W., Mohammed, M., Dayo, H., Snow, R.W., Marsh, K., 2005. Clinical algorithms
for malaria diagnosis lack utility among people of different age groups. Trop. Med. Int.
Health 10, 530-536.
Myint, H.Y., Tipmanee, P., Nosten, F., Day, N.P., Pukrittayakamee, S., et al., 2004. A systematic
overview of published antimalarial drug trials. Trans. R. Soc. Trop. Med. Hyg. 98, 73-81.
Nkhoma, E.T., Poole, C.,Vannappagari,V., Hall, S.A., Beutler, E., 2009. The global prevalence
of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analy-
sis. Blood Cells Mol. Dis. 42, 267-278.
Nomura, T., Carlton, J.M., Baird, J.K., del Portillo, H.A., Fryauff, D.J., et al., 2001. Evidence
for different mechanisms of chloroquine resistance in 2
Plasmodium
species that cause
human malaria. J. Infect. Dis. 183, 1653-1661.
Nurleila, S., Syafruddin, D., Elyazar, I.R.F., Baird, J.K., 2012. Serious and fatal illness associ-
ated with falciparum and vivax malaria among patients admitted to hospital at West
Sumba in Eastern Indonesia. Am. J. Trop. Med. Hyg. 87, 41-49.
Obaldia 3rd, N., Rossan, R.N., Cooper, R.D., Kyle, D.E., Nuzum, E.O., et al., 1997. WR
238605, chloroquine, and their combinations as blood schizonticides against a chloro-
quine-resistant strain of
Plasmodium vivax
in Aotus monkeys. Am. J. Trop. Med. Hyg.
56, 508-510.
Office of the Surgeon General, 1943. The drug treatment of malaria, suppressive and clinical.
Circular Letter No. 153 J. Am. Med. Assoc. 123, 205-208.
O'Meara, W.P., Barcus, M., Wongsrichanalai, C., Muth, S., Maguire, J.D., et al., 2006. Reader
technique as a source of variability in determining malaria parasite density by micros-
copy. Malar. J. 5, 118.
Pannacciulli, I., Tizianello, A., Ajmar, F., Salvidio, E., 1965. The course of experimentally
induced hemolytic anemia in a primaquine sensitive Caucasian. Blood 25, 92-95.
Path, 2011. Staying the course? Malaria Research and Development in a Time of Economic
Uncertainty. Seattle PATH, 87 pp.
Perisse, A.R., Strickland, G.T., 2008. Usefulness of clinical algorithm as screening process
to detected malaria in low-to-moderate transmission areas of scarce health related
resources. Acta Trop. 107, 224-229.
Perren, A., Beretta, F., Schubarth, P., 1998. ARDS in
Plasmodium vivax
malaria. Schweiz. Med.
Wochenschr. 128, 1020-1023.
Phyo, A.P., Lwin, K.M., Price, R.N., Ashley, E.A., Russell, B., et al., 2011. Dihydroartemisinin-
piperaquine versus chloroquine in the treatment of
Plasmodium vivax
malaria in Thailand: a
randomized controlled trial. Clin. Infect. Dis. 53, 977-984.
